- Home
- ARQT vs COCO Comparison
ARQT vs COCO Comparison
Compare ARQT & COCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- COCO
- Stock Information
- Founded
- ARQT 2016
- COCO 2004
- Country
- ARQT United States
- COCO United States
- Employees
- ARQT N/A
- COCO N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- COCO Beverages (Production/Distribution)
- Sector
- ARQT Health Care
- COCO Consumer Staples
- Exchange
- ARQT Nasdaq
- COCO Nasdaq
- Market Cap
- ARQT 1.7B
- COCO 1.8B
- IPO Year
- ARQT 2020
- COCO 2021
- Fundamental
- Price
- ARQT $15.99
- COCO $36.73
- Analyst Decision
- ARQT Strong Buy
- COCO Buy
- Analyst Count
- ARQT 7
- COCO 8
- Target Price
- ARQT $19.00
- COCO $38.00
- AVG Volume (30 Days)
- ARQT 1.8M
- COCO 817.1K
- Earning Date
- ARQT 08-06-2025
- COCO 07-30-2025
- Dividend Yield
- ARQT N/A
- COCO N/A
- EPS Growth
- ARQT N/A
- COCO 14.02
- EPS
- ARQT N/A
- COCO 1.07
- Revenue
- ARQT $263,464,999.00
- COCO $559,879,000.00
- Revenue This Year
- ARQT $61.83
- COCO $13.79
- Revenue Next Year
- ARQT $36.55
- COCO $11.16
- P/E Ratio
- ARQT N/A
- COCO $34.28
- Revenue Growth
- ARQT 99.50
- COCO 11.97
- 52 Week Low
- ARQT $8.03
- COCO $24.09
- 52 Week High
- ARQT $17.75
- COCO $40.32
- Technical
- Relative Strength Index (RSI)
- ARQT 56.88
- COCO 62.13
- Support Level
- ARQT $15.43
- COCO $31.92
- Resistance Level
- ARQT $17.29
- COCO $36.32
- Average True Range (ATR)
- ARQT 0.97
- COCO 0.99
- MACD
- ARQT 0.06
- COCO 0.44
- Stochastic Oscillator
- ARQT 63.70
- COCO 94.01
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About COCO The Vita Coco Company Inc.
The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.